https://www.statcounter.com/counter/counter.js
Web Analytics
Home » Posts tagged with » Sandoz
Italian CDMO Olon wraps up acquisition of Mahad API plant in India

Italian CDMO Olon wraps up acquisition of Mahad API plant in India

Mahad API plant acquisition : Olon, an Italy-based active pharmaceutical ingredients (API) developer and manufacturer, has completed the acquisition of an API manufacturing facility in Mahad in Maharashtra, India. The company’s subsidiary Olon India will initiate all the activities the next April 1st as per the strategy of Olon after an intensive transition period that […]

US CDMO Avara acquires sterile manufacturing facility in Boucherville from Sandoz

Avara Pharmaceutical Services, a US CDMO (contract development and manufacturing organization), has completed a previously announced acquisition of a Canadian sterile manufacturing facility for injectable medicines in Boucherville, Quebec, from Novartis’ Sandoz division. The financial terms of the acquisition of the injectables production facility were not disclosed. The deal, which marks the entry of the […]

Continue reading …
Hyrimoz EC approval : Novartis biosimilar of AbbVie Humira approved in EU

Hyrimoz EC approval : Novartis’ Sandoz has bagged approval for Hyrimoz (adalimumab), a biosimilar of AbbVie’s Humira (adalimumab), in Europe for all indications of the reference drug including rheumatoid arthritis, Crohn’s disease, plaque psoriasis, uveitis and ulcerative colitis. The approval of Hyrimoz by European Commission (EC) was driven by analytical, preclinical and clinical research that […]

Continue reading …
Slayback Pharma launches genital herpes ointment – Zovirax Ointment 5%

Slayback Pharma has launched its genital herpes ointment Generic Zovirax Ointment (Acyclovir Ointment) 5% in the US. The launch of the genital herpes ointment was done through its out-licensee – Sandoz (Fougera), a generic drug subsidiary of Novartis, which holds the sales and marketing rights of the Slayback product. Sandoz secured the Abbreviated New Drug […]

Continue reading …